Your session is about to expire
← Back to Search
Group 1: Quadrivalent Influenza mRNA Vaccine MRT5407 dose level 1 for Influenza Immunization
Study Summary
This trial is testing the safety and effectiveness of a new influenza vaccine compared to existing ones.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2012 Phase 3 trial • 6104 Patients • NCT01346592Trial Design
Find a Location
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Travel, including flights, are covered
Your expenses for travel tickets for this trial will be reimbursed.
Other reimbursement is provided
Other forms of reimbursement are provided for this trial.
Who is running the clinical trial?
Media Library
- You are at least 18 years old.Your immune system is working properly.You cannot have children, either because you have gone through menopause or have had a surgical procedure to prevent pregnancy. If you can have children, you need to use a reliable form of birth control for at least 4 weeks before starting the study and for 12 weeks after the study ends.You have not received an mRNA vaccine in the last two months.
- Group 1: Group 5: QIV-HD
- Group 2: Group 4: QIV-SD
- Group 3: Group 1: Quadrivalent Influenza mRNA Vaccine MRT5407 dose level 1
- Group 4: Group 2: Quadrivalent Influenza mRNA Vaccine MRT5407 dose level 2
- Group 5: Group 3: RIV4
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: You will receive the treatment for 1 null
- Follow Ups: You may be asked to continue sharing information regarding the trial for 12 Months after you stop receiving the treatment.
Frequently Asked Questions
How many venues is this clinical research taking place in?
"This trial is currently open at 5 sites, including Lexington and Austin, with other locations in Knoxville plus an additional five. To reduce travel time for potential participants, it may be wise to select the nearest site of enrolment."
Is recruitment open for the current trial?
"Per clinicaltrials.gov, this medical trial is currently advertising for participants. The listing was first published on October 3rd 2022 and recently updated 6 days later."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
What questions have other patients asked about this trial?
How responsive is this trial?
Typically responds via
Share this study with friends
Copy Link
Messenger